LU82103A1 - Compositions de contraste pour l'angiographie - Google Patents

Compositions de contraste pour l'angiographie Download PDF

Info

Publication number
LU82103A1
LU82103A1 LU82103A LU82103A LU82103A1 LU 82103 A1 LU82103 A1 LU 82103A1 LU 82103 A LU82103 A LU 82103A LU 82103 A LU82103 A LU 82103A LU 82103 A1 LU82103 A1 LU 82103A1
Authority
LU
Luxembourg
Prior art keywords
contrast
compound
perfluorocarbon
contrast composition
composition according
Prior art date
Application number
LU82103A
Other languages
English (en)
French (fr)
Inventor
J Wada
T Itaoka
Original Assignee
J Wada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Wada filed Critical J Wada
Publication of LU82103A1 publication Critical patent/LU82103A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Meat, Egg Or Seafood Products (AREA)
LU82103A 1979-01-25 1980-01-22 Compositions de contraste pour l'angiographie LU82103A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP743779A JPS55100312A (en) 1979-01-25 1979-01-25 Contrast medium for blood vessel
JP743779 1979-01-25

Publications (1)

Publication Number Publication Date
LU82103A1 true LU82103A1 (fr) 1980-04-23

Family

ID=11665829

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82103A LU82103A1 (fr) 1979-01-25 1980-01-22 Compositions de contraste pour l'angiographie

Country Status (22)

Country Link
US (1) US4285928A (de)
JP (1) JPS55100312A (de)
AR (1) AR229084A1 (de)
AT (1) AT369266B (de)
AU (1) AU517412B2 (de)
BE (1) BE881324A (de)
CA (1) CA1140849A (de)
CH (1) CH646062A5 (de)
DD (1) DD148719A5 (de)
DE (1) DE3002004C2 (de)
DK (1) DK156621C (de)
FI (1) FI77984C (de)
FR (1) FR2447195A1 (de)
GB (1) GB2041221B (de)
IL (1) IL59149A (de)
IT (1) IT1143008B (de)
LU (1) LU82103A1 (de)
NL (1) NL187894C (de)
NO (1) NO152863C (de)
NZ (1) NZ192600A (de)
SE (1) SE445973B (de)
ZA (1) ZA80287B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490351A (en) * 1982-03-15 1984-12-25 Children's Hospital Medical Center Methods of treating disorders of an eye with liquid perfluorocarbons
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
JPS5946230A (ja) * 1982-09-08 1984-03-15 Green Cross Corp:The 造影剤
US4640833A (en) * 1983-02-28 1987-02-03 Adamantech, Inc. Use of perfluorobromoalkyl ethers as X-ray contrast agents
US4567034A (en) * 1984-09-07 1986-01-28 E. R. Squibb & Sons, Inc. Esters of diatrizoic acid as X-ray contrast agents
US4767610A (en) * 1984-10-19 1988-08-30 The Regents Of The University Of California Method for detecting abnormal cell masses in animals
US4680171A (en) * 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
US5847009A (en) * 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
WO1989008459A1 (en) * 1988-03-11 1989-09-21 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
US5061484A (en) * 1988-03-11 1991-10-29 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
GB8919929D0 (en) * 1989-09-04 1989-10-18 Nycomed As Compositions
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
US5350359A (en) * 1992-07-16 1994-09-27 Temple University Of The Commonwealth System Of Higher Education Control, treatment and/or diagnosis of physiological conditions with degassed perfluorocarbon liquid
US5741248A (en) * 1995-06-07 1998-04-21 Temple University-Of The Commonwealth System Of Higher Education Fluorochemical liquid augmented cryosurgery
DE19731300C1 (de) * 1997-07-11 1999-01-21 Schering Ag Perfluoralkylgruppenhaltige Trijodaromaten, Verfahren zu deren Herstellung und deren Verwendung als Kontrastmittel
DE19731591C2 (de) * 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2832722A (en) * 1953-07-15 1958-04-29 Ortho Pharma Corp Radiopaque formulation comprising pvp as bodying agent
US3818229A (en) * 1970-12-21 1974-06-18 Univ Illinois Radiopaque agents comprising brominated perfluorocarbons
DE2163191C2 (de) * 1970-12-21 1982-07-01 The University of Illinois Foundation, Urbana, Ill. Röntgenkontrastmittel
US3975512A (en) * 1970-12-21 1976-08-17 University Of Illinois Foundation Non-toxic brominated perfluorocarbons radiopaque agents
BE788054A (fr) * 1971-08-26 1973-02-26 Bracco Ind Chimica Spa Nouvel agent de contraste radiographique et procede pour le preparer
JPS5331209B2 (de) * 1973-10-05 1978-09-01
US4073879A (en) * 1974-08-26 1978-02-14 University Of Illinois Foundation Brominated perfluorocarbon radiopaque agents
US3975572A (en) * 1975-12-22 1976-08-17 Formica Corporation Thin, tough, stable, mar-resistant laminate
JPS5835485B2 (ja) * 1976-02-03 1983-08-03 株式会社ミドリ十字 酸素運搬輸液

Also Published As

Publication number Publication date
DK156621B (da) 1989-09-18
DE3002004A1 (de) 1980-07-31
DK3580A (da) 1980-07-26
NL187894C (nl) 1992-02-17
IT8047643A0 (it) 1980-01-18
AU517412B2 (en) 1981-07-30
AT369266B (de) 1982-12-27
DD148719A5 (de) 1981-06-10
NL8000310A (nl) 1980-07-29
GB2041221B (en) 1983-03-09
FR2447195A1 (fr) 1980-08-22
JPS617171B2 (de) 1986-03-04
IT1143008B (it) 1986-10-22
FI77984B (fi) 1989-02-28
IL59149A0 (en) 1980-05-30
AU5464780A (en) 1980-07-31
AR229084A1 (es) 1983-06-15
FR2447195B1 (de) 1983-08-19
NO152863C (no) 1985-12-04
DE3002004C2 (de) 1983-08-04
NZ192600A (en) 1982-03-23
IL59149A (en) 1983-03-31
JPS55100312A (en) 1980-07-31
ATA39080A (de) 1982-05-15
BE881324A (fr) 1980-05-16
ZA80287B (en) 1980-12-31
SE445973B (sv) 1986-08-04
NO800164L (no) 1980-07-28
GB2041221A (en) 1980-09-10
FI77984C (fi) 1989-06-12
NO152863B (no) 1985-08-26
FI800195A (fi) 1980-07-26
CH646062A5 (de) 1984-11-15
CA1140849A (en) 1983-02-08
DK156621C (da) 1990-02-05
US4285928A (en) 1981-08-25
SE8000074L (sv) 1980-07-26

Similar Documents

Publication Publication Date Title
LU82103A1 (fr) Compositions de contraste pour l'angiographie
BE1005531A5 (fr) Agents bloquants de l'effet ou de la formation du facteur edrf pour le traitement des chocs.
Mok et al. Structured medium-chain and long-chain triglyceride emulsions are superior to physical mixtures in sparing body protein in the burned rat
EP0316993B1 (de) Pharmazeutische Zusammensetzungen mit Gehalt an einem Derivat der 3-Hydroxy-Buttersäure, ausgewählt aus den Oligomeren dieser Säure und den Estern dieser Säure oder dieser Oligomere mit dem 1,3-Butan-diol
EP0593601A1 (de) Taxan-derivate enthaltende arzneimittel
DE69008258T2 (de) S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.
Edgren et al. The theoretical background of the intravenous nutrition with fat emulsions
JPH0357087B2 (de)
Brauer et al. The relation between the esterase activity of the blood plasma and of the liver of the dog
Waxman Perfluorocarbons as blood substitutes
WO1993010792A1 (fr) Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs
FR2700696A1 (fr) Dispersions, émulsions, microémulsions, gels et compositions à usage biomédical comprenant un composé organique fluoré iodé, utilisables notamment comme agent de contraste.
WO1998008500A1 (en) Hypertonic arginine compositions and methods
Green Experimental hypertension
US5554650A (en) Antiphlogistic, analgesic, antipyretic injection preparation
LU84614A1 (fr) Perfluorocyclo-amines et preparation en emulsion contenant ces perfluorocyclo-amines
US4767783A (en) Gallstone dissolver
CA1275247C (fr) Procede de solubilisation, au moment de l'emploi, d'un principe actiflipophile dans une solution aqueuse, en vue de son administration par voie intraveineuse
JPH0761924A (ja) 腸内細菌の血中転移を抑制する輸液製剤
JPH03501027A (ja) エネルギー基質
Connolly et al. MDMA toxicity presenting with severe hyperpyrexia: a case report
BE1000100A5 (fr) Agent ameliorant pour la fibrose pulmonaire et son utilisation.
US4921849A (en) Injection containing 3-benzoyloxy-1,3,5(10)-estratriene-17-[4-{p-(bis(2-chloroethyl)amino)phenyl}butanoyloxy)acetate as an active ingredient
JPH11509206A (ja) 虚血性腸組織における好中球浸潤および形態学的喪失の遅延のためのピルベートの使用
Jamieson et al. Heart and lung transplantation for pulmonary hypertension